scispace - formally typeset
S

Sigve Nakken

Researcher at University of Oslo

Publications -  63
Citations -  2387

Sigve Nakken is an academic researcher from University of Oslo. The author has contributed to research in topics: Cancer & Lynch syndrome. The author has an hindex of 19, co-authored 54 publications receiving 1696 citations. Previous affiliations of Sigve Nakken include Oslo University Hospital & Rikshospitalet–Radiumhospitalet.

Papers
More filters
Journal ArticleDOI

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database

TL;DR: Carriers of different path_MMR variants exhibit distinct patterns of cancer risk and survival as they age, and risk estimates for counselling and planning of surveillance and treatment should be tailored to each patient’s age, gender and path-MMR variant.
Journal ArticleDOI

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Mev Dominguez-Valentin, +94 more
- 01 Jan 2020 - 
TL;DR: Management guidelines for Lynch syndrome may require revision in light of these different gene and gender-specific risks and the good prognosis for the most commonly associated cancers.
Journal ArticleDOI

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing

Tyler Alioto, +93 more
TL;DR: It is shown that using PCR-free methods and increasing sequencing depth to ∼100 × shows benefits, as long as the tumour:control coverage ratio remains balanced, and many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy.
Journal ArticleDOI

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.

TL;DR: In this paper, the authors address three questions: (i) what is the cumulative incidence of a subsequent cancer; (ii) in which organs do subsequent cancers occur; and (iii) the survival following these cancers? Design Information was collated on prospectively organized surveillance and prospectively observed outcomes in patients with Lynch syndrome who had cancer prior to inclusion and analysed by age, gender and genetic variants.